Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 2006Journal of Bone and Mineral ResearchOpen Access

Effects of 3- and 5-Year Treatment With Risedronate on Bone Mineralization Density Distribution in Triple Biopsies of the Iliac Crest in Postmenopausal Women

View Full Paper
Ask AI
Bookmark
Share

Authors

RZRuth ZoehrerOrthopaedic Hospital SpeisingPRPaul RoschgerHanusch HospitalEPEleftherios P. PaschalisRutgers, The State University of New Jersey

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zoehrer et al. (2006) studied this question.

synapsesocial.com/papers/6aa71a7627595b7b7ae08d9ahttps://doi.org/10.1359/jbmr.060401
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis A Randomized Controlled Trial1999 · 2,491 citations
  2. 2Relationship Between Changes in BMD and Nonvertebral Fracture Incidence Associated With Risedronate: Reduction in Risk of Nonvertebral Fracture Is Not Related to Change in BMD2005 · 164 citations
  3. 3Treatment With Once-Weekly Alendronate 70 mg Compared With Once-Weekly Risedronate 35 mg in Women With Postmenopausal Osteoporosis: A Randomized Double-Blind Study2005 · 339 citations